To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions

Clinical trial NCT07042828 · COMPLETED

Trial details

NCT number: NCT07042828
Sponsor: Humanis Saglık Anonim Sirketi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allergic Rhino-Conjunctivitis Urticaria

Start date: 2025-04-30
Primary completion: 2025-06-16
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.